Generic Pharmaceuticals Industry Top 200 Generic Pharmaceuticals Industry (Global)

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

DOWNLOAD THESE REPORTS NOW!

Strides Arcolab Limited (STAR) - Financial and Strategic SWOT Analysis Review

Strides Arcolab Limited (STAR) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • March 2013
  • 25 pages

Summary Strides Arcolab Limited (Strides Arcolab) is a pharmaceutical company. It carries out the manufacture and export of finished branded and generic drugs. The company offers gelatin capsules and sterile parenterals. Its business is divided into two product lines, namely, Generics and Specialties. ...

Industries: Generic Drug | Countries: Poland, India, United States, Singapore, World

Apotex, Inc. SWOT Analysis, Strategy, Revenues and Profits

Apotex, Inc. SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • by Global Data
  • February 2013
  • 26 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: Generic Drug | Countries: Czech Republic, Saudi Arabia, World, New Zealand, Australia, Netherlands, United States, Mexico, Poland, Italy, Belgium

Generic Growth Strategies - Market Driven by Impending Patent Cliff, Declining R&D Productivity and Government Initiatives to Reduce Healthcare Costs

Generic Growth Strategies - Market Driven by Impending Patent Cliff, Declining R&D Productivity and Government Initiatives to Reduce Healthcare Costs

  • $ 3 500
  • Industry report
  • by GBI Research
  • December 2012
  • 78 pages

Generic Growth Strategies - Market Driven by Impending Patent Cliff, Declining R&D Productivity and Government Initiatives to Reduce Healthcare Costs Summary GBI Research, the leading business intelligence provider, has released its latest research, ?Generic Growth Strategies - Market Driven by Impending ...

Industries: Generic Drug | Countries: Europe, United States, World, Japan, Spain, Italy, France, Germany

Apotex, Inc.: Pharmaceuticals and Healthcare Company Profile & SWOT Report

Apotex, Inc.: Pharmaceuticals and Healthcare Company Profile & SWOT Report

  • $ 125
  • Company report
  • by ICD Research
  • November 2012
  • 13 pages

Synopsis ICD Research's "Apotex, Inc.: Pharmaceuticals and Healthcare - Company Profile & SWOT Report" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts,major products and services, swot analysis, business description, and ...

Industries: Generic Drug | Countries: Canada, Czech Republic, New Zealand, Australia, Netherlands, Mexico, Poland, Belgium, World, Europe, Oceania, North America, United Kingdom

Global Biosimilars Market - Products, Applications and Regulations

Global Biosimilars Market - Products, Applications and Regulations

  • $ 4 320
  • Industry report
  • by Industry Experts
  • November 2012
  • 354 pages

Several of the leading 25 manufacturers of biosimilars have been entrenched in the market, and have the experience of marketing products for the last 5-10 years. On the other hand, several companies' position is expected to be challenged over the next ten years, since the rapid growth forecast for the ...

Industries: Generic Drug | Countries: World, Europe, United States, United Kingdom, Germany, France, Spain, Italy, India, South Korea

Top 198 Generic Pharmaceuticals (Global)

Top 198 Generic Pharmaceuticals (Global)

  • $ 1 523
  • Industry report
  • by Plimsoll Publishing Ltd UK
  • November 2012

This report is an in-depth financial evaluation of the Global Generic Pharmaceuticals. Using the unique Plimsoll method of analysis, each of the largest 198 companies is individually assessed and ranked against each other and compared to industry averages.Using the most up-to-date financial information ...

Industries: Generic Drug | Countries: World

Generic Drugs: World Market 2013-2023

Generic Drugs: World Market 2013-2023

  • $ 2 492
  • Industry report
  • by Visiongain
  • November 2012
  • 149 pages

Report Details Your guide to trends and sales potential for generics Where's the generic drugs market heading? Visiongain's updated report gives you revenue predictions to 2023. There you find data, trends, opportunities and commercial prospects. That new study lets you assess forecasted sales at overall ...

Industries: Generic Drug | Countries: World

Generics: World Market Overview (Market size, Segmentation and Trends Analysis)

Generics: World Market Overview (Market size, Segmentation and Trends Analysis)

  • $ 1 495
  • Industry report
  • by MarketLine
  • August 2012
  • 253 pages

It includes detailed data on industry size and sector ation, textual analysis of the key trends and competitive landscape, and profiles of the leading firms . This incisive report provides expert analysis on a global, regional and country basis. Scope of the Report * Contains an executive summary and ...

Industries: Generic Drug | Countries: World, Europe, United States, United Kingdom, Netherlands, France, Germany, Japan, Canada, Spain, Italy, Belgium, China

Global Generics, MarketLine

Global Generics, MarketLine

  • $ 350
  • Industry report
  • by MarketLine
  • July 2012
  • 35 pages

Introduction Global Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures ...

Industries: Generic Drug | Countries: World

Biosimilars in Developed Countries - Launch of Biosimilar mAbs in Europe and New Regulatory Pathways in the US to Spur Market Growth

Biosimilars in Developed Countries - Launch of Biosimilar mAbs in Europe and New Regulatory Pathways in the US to Spur Market Growth

  • $ 3 500
  • Industry report
  • by GBI Research
  • July 2012
  • 141 pages

Summary GBI Research, the leading business intelligence provider, has released its latest report, ?Biosimilars in Developed Countries - Launch of Biosimilar mAbs in Europe and New Regulatory Pathways in the US to Spur Market Growth? that provides key data, information and analysis of the major trends ...

Industries: Generic Drug | Countries: Europe, United States, World, Japan

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • (866) 682 9815

Privacy Policy by TRUSTe
ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.